Atlas Trials

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy

Clinical trial NCT01676220 · COMPLETED

Trial details

NCT number
NCT01676220
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2012-08-01
Primary completion
2013-09-01
Enrollment
878

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.